Lonza Group Ag Net Cash Flow 2012-2024 | LZAGY
Lonza Group Ag annual/quarterly net cash flow history and growth rate from 2012 to 2024. Net cash flow can be defined as the total change in cash for the company over the given period.
- Lonza Group Ag net cash flow for the quarter ending December 31, 2024 was $-0.406B, a 599.24% increase year-over-year.
- Lonza Group Ag net cash flow for the twelve months ending December 31, 2024 was $-0.117B, a 111.3% decline year-over-year.
- Lonza Group Ag annual net cash flow for 2023 was $0.144B, a 156.43% decline from 2022.
- Lonza Group Ag annual net cash flow for 2022 was $-0.255B, a 124.17% decline from 2021.
- Lonza Group Ag annual net cash flow for 2021 was $1.054B, a 766.52% increase from 2020.
| Lonza Group Ag Annual Net Cash Flow (Millions of US $) |
|
|---|---|
| 2023 | $144 |
| 2022 | $-255 |
| 2021 | $1,054 |
| 2020 | $122 |
| 2019 | $23 |
| 2017 | $208 |
| 2016 | $1 |
| 2015 | $71 |
| 2014 | $-106 |
| 2013 | $-133 |
| 2012 | $249 |
| 2011 | $-59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $51.526B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||